Waiting for a lung transplant in the intensive care unit at a New York hospital in November 2017, a 21-year-old…
Articles by Emma Yasinski
Vertex Pharmaceuticals announced it plans to request by year’s end that the label for Symdeko (tezacaftor/ivacaftor and ivacaftor), its recently…
Editor’s note: This is the last of a four-part series looking at Vertex Pharmaceuticals and its “all in for CF”…
Editor’s note: This is third in a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach.
Editor’s Note: This is the second of a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach.
Editor’s note: This is the first of a four-part series looking at Vertex Pharmaceuticals and its “all in for CF” approach.
Five scientists whose work has been instrumental in developing disease-modifying treatments for cystic fibrosis (CF) are recipients of the 2018Â …